BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6800217)

  • 1. Sustained effect of hydralazine in long term treatment of CHF.
    Conradson TB; Rydén L
    Acta Med Scand Suppl; 1981; 652():173-6. PubMed ID: 6800217
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydralazine in chronic CHF.
    Chatterjee K; Rouleau JL; Massie BM
    Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
    Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.
    Chatterjee K; Ports TA; Brundage BH; Massie B; Holly AN; Parmley WW
    Ann Intern Med; 1980 May; 92(5):600-4. PubMed ID: 7386999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure.
    Siegel LA; Keung E; Siskind SJ; Forman R; Feinberg H; Strom J; Efstathakis D; Sonnenblick EH; LeJemtel TH
    Circulation; 1981 Apr; 63(4):838-44. PubMed ID: 7471340
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 7. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
    Greenberg BH; Massie BM
    Circulation; 1980 Jun; 61(6):1212-6. PubMed ID: 7371134
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
    Elkayam U; Weber L; McKay CR; Rahimtoola SH
    Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
    LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
    Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
    [No Abstract]   [Full Text] [Related]  

  • 10. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
    Drexler H; Löllgen H; Just H
    Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
    [No Abstract]   [Full Text] [Related]  

  • 11. Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up.
    Greenberg BH; DeMots H; Murphy E; Rahimtoola SH
    Circulation; 1982 Jan; 65(1):181-7. PubMed ID: 7053281
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
    Rubin LJ; Peter RH
    Am J Cardiol; 1981 Jan; 47(1):116-22. PubMed ID: 7457397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of nifedipine in congestive heart failure.
    Matsumoto S; Ito T; Sada T; Takahashi M; Su KM; Ueda A; Okabe F; Sato M; Sekine I; Ito Y
    Am J Cardiol; 1980 Sep; 46(3):476-80. PubMed ID: 7415993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.
    Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV
    Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.
    Rubin LJ; Handel F; Peter RH
    Circulation; 1982 Jun; 65(7):1369-73. PubMed ID: 7074795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of dobutamine in children with cardiovascular failure.
    Schranz D; Stopfkuchen H; Jüngst BK; Clemens R; Emmrich P
    Eur J Pediatr; 1982 Sep; 139(1):4-7. PubMed ID: 7173256
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
    Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
    Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
    Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
    Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and regional blood flow distribution responses to dextran, hydralazine, isoproterenol and amrinone during experimental cardiac tamponade.
    Millard RW; Fowler NO; Gabel M
    J Am Coll Cardiol; 1983 Jun; 1(6):1461-70. PubMed ID: 6189872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.